T he spine is the most common site of bony metastases, with 50% of all skeletal metastases occurring in the spine. 9, 14 Among patients whose cause of death is malignant neoplasm, an estimated 30.6% have spinal metastases based on microscopic examination. 27 Certain primary tumors, such as lung, breast, and prostate, have a higher frequency of metastases to the spinal column.
5%-10% of all cancer patients. 26 Spinal cord compression can cause disability and significantly impair quality of life. 42 Although some patients with spinal metastases can be treated nonoperatively, patients who present with spinal cord compression often require surgical intervention to preserve neurological function. 14 Decompression surgery is the standard surgical technique used to treat metastatic disease of the thoracic and lumbar spine. 10 Location of metastatic disease determines the approach for decompression surgery. A ventral or dorsal approach, or both, can be used in the cervical, thoracic, and lumbar spine, depending on several factors. These include location of compression, goals of reconstruction if necessary, type of tumor, surgeon expertise, and patientspecific factors (e.g. comorbidities of body habitus). 8 Although outcomes following decompression surgery have been reported in the literature for 5 decades, a systematic review of predictors of outcome following decompression surgery for spinal metastases has not been performed. The present study systematically reviews the current literature and examines reported outcomes following decompression surgery for spinal metastases. Specifically, we highlight predictors of survival and predictors of ambulation, as well as surgical techniques, neurological function outcomes, primary tumor histology outcomes, and miscellaneous outcomes.
Methods study search
A systematic review was conducted in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). We conducted database searches of MEDLINE, Scopus, and Web of Science using the following search algorithm: (decompr* OR separat*) AND (spine or spina*) AND metasta* AND (surge* OR surgi*). This search returned 4148 citations (Fig. 1 ). The search period ended on January 22, 2016.
inclusion and exclusion Criteria
Clinical studies reporting outcomes of decompression surgery for spinal metastases were included within the study. Animal, in vitro, biomechanical, non-English language studies, book chapters, and case reports (defined as n < 10) were excluded. Due to the limited amount of data available, both retrospective and prospective studies were included.
Data Collection
Two reviewers (D.B. and K.P.) independently evaluated the initial 4148 retrieved citations. After removing 1914 duplicates, the titles and abstracts of 2234 publications were screened. 24 Of these studies, 2119 citations did not meet the inclusion criteria. The full text of the remaining 115 articles was assessed. This resulted in 36 eligible articles included in the final analysis. The following data were collected from the eligible articles: publication year, study type, number of patients, primary cancer histology, and outcomes reported. We assessed the level of evidence in the included articles using the Oxford Centre for Evidence Based Medicine Level of Evidence 2 classification system (http://www.cebm.net/ocebm-levelsof-evidence/). The risk of bias was not assessed because most included studies were retrospective case series that have strong inherent bias. Following initial review, studies were categorized into one or more of the following categories: predictors of survival, predictors of ambulation, surgical technique, neurological function, primary tumor histology, and miscellaneous outcomes.
results study Characteristics
A total of 36 studies met inclusion and exclusion criteria. Of the 36 included studies, 8 were prospective studies and 28 were retrospective studies. The year of publication ranged from 1992 to 2015. Study size ranged from 21 to 711 patients. Data extracted from these reports are presented in Tables 1-6 .
Predictors of survival
Nineteen studies reported predictors of survival for patients with spinal metastases who underwent decompression surgery (Table 1) . 2, 3, 5, 7, 15, 18, 19, 21, 25, 28, [30] [31] [32] 34, 35, 37, 38, 40, 43 Of these, 16 studies were retrospective; 1 was a longitudinal observational study; 1 was a randomized, multiinstitutional, nonblinded trial; and 1 was a semiprospective study that included both retrospectively and prospectively collected data. Surgical interventions included decompression with and without instrumentation and radiotherapy. Primary histology of tumors varied widely; however, prostate cancer (14 studies), lung cancer (13 studies), breast cancer (10 studies), and renal cancer (6 studies) were commonly reported in the included studies.
In a multivariable analysis of 105 patients with predominantly lung cancer as the primary tumor site, Chong et al. 5 found that a limited number (< 3 levels) of spinal metastases and postoperative adjuvant therapy (local irradiation only, chemotherapy only, or irradiation and systemic chemotherapy) were associated with increased survival (HR of 0.53 and 0.48, respectively, both p < 0.05). Padalkar et al. 28 studied 102 patients and found that metastases to internal organs (p < 0.001) and increased number of extraspinal bony metastases (p < 0.01) were significantly associated with worse odds of survival. In a longitudinal observational study, Park et al. 31 used a multivariable analysis to find that time to neurological deficit (risk ratio [RR] 2.28, p = 0.02), postoperative chemotherapy (RR 6.58, p < 0.001), and postoperative Eastern Cooperative Oncology Group (ECOG) performance status (RR 2.73, p = 0.04) were independent predictors of increased survival time. No study reported a significant effect of time-to-surgery following the onset of spinal cord compression symptoms on survival. 36 Quraishi et al. 36 reported that there was no significant difference between 3 groups treated with surgery within 24 hours, between 24 and 48 hours, and over 48 hours from acute presentation of neurological symptoms with respect to survival (p = 0.99). Finally, in a randomized, multiinstitutional, nonblinded trial, Patchell et al. 32 found that surgical treatment followed by radiotherapy compared with radiotherapy alone resulted in increased median survival time (126 days vs 100 days, respectively; RR 0.6, p = 0.03).
Several studies established scoring systems for prediction of survival following decompression surgery for various primary tumor sites. Crnalic et al. 7 established a scoring system for prediction of survival following decompression surgery based on the results of survival analyses of patients with prostate cancer metastatic to the spine. The authors included the hormone status of patients' prostate cancer, preoperative Karnofsky Performance Status (KPS), evidence of visceral metastasis, and preoperative serum prostate-specific antigen (PSA) in calculating the new prediction score. 7 The authors found that hormone status was strongly associated with survival in their patients as well as in 2 other studies of spinal cord compression in patients with prostate cancer. Consequently, the authors assigned maximal weight to hormone status in their score. 7 Additionally, the authors noted that KPS was the strongest predictor of survival in the their hormonerefractory patients. 7 Lei et al. 21 sought to establish a scoring system for survival and functional outcome among patients undergoing posterior decompression surgery for lung cancer metastatic to the spine. The authors found that preoperative ambulatory status (p < 0.01), visceral metastases (p < 0.001), and time to developing motor deficits (p < 0.001) were significant predictors of survival and were therefore included in the scoring system. 21 In a separate study, Lei et al. 19 also created a scoring system to predict survival prognosis among patients with metastatic non-small cell lung cancer causing spinal cord compression who underwent surgical decompression. The authors included the following components as part of their scoring system: ECOG performance status (p = 0.02), number of involved verte- The median postop survival time did not significantly decrease w/ an increasing no. of recurrences.
In patients w/ prostate cancer, median survival after 1st reop was 8.2 mos (95% CI 3.8-14.1 mos) & 6.0 mos after last operation (lower 95% confidence limit 2.4 mos-upper bound after 1st reop could not be estimated since >50% of these patients were ambulatory at the conclusion of the study (lower 95% confidence limit 5.7 mos).
In patients w/ renal cancer, outcomes were even more favorable. The median survival time after 1st reop was 13.7 mos (95% CI 6. Two studies investigated survival based on Tokuhashi scores. Park et al. 30 reported that the median overall survival times were significantly longer in patients with high (9-11) preoperative Tokuhashi scores (15.0 months [95% CI 9.3-20.7 months]) relative to patients with low (0-8) preoperative Tokuhashi scores (9.0 months [95% CI 7.5-10.5 months]) (p < 0.01). Similarly, Vanek et al. 43 found that Tokuhashi scores were a significant and independent predictor of survival following decompression surgery for spinal metastases (p < 0.001).
One study found an association between Motzer scores and survival. Bakker et al. 2 determined that among patients with renal cell carcinoma metastatic to the spine, 
Predictors of Ambulatory status or Motor Function
Sixteen studies reported predictors of postoperative ambulatory status and motor function following decompression surgery for spinal metastases (Table 2) . 1, 3, 4, 13, [16] [17] [18] [19] [20] 22, [29] [30] [31] 33, 38, 39 Fifteen studies were retrospective, and one was a longitudinal observational study. Eleven studies 1, 3, 4, 18, 20, 22, [29] [30] [31] 33, 39 reported outcomes following surgery alone, and 5 studies 13, 16, 17, 19, 38 reported the effects of decompression surgery with radiotherapy. Primary tumor sites included lung (15 studies), breast (13 studies), prostate (12 studies), gastrointestinal (8 studies), and renal (4 studies).
Eight studies reported that preoperative ambulatory or preoperative motor status was a significant predictor of postoperative ambulatory status (Table 2) . 4, 13, 16, 20, [29] [30] [31] 33 Chaichana et al. 4 reported that preoperative ability to walk (RR 2.3 [95% CI 1.3-4.4], p < 0.01) was a positive predictor of postoperative ambulatory status, whereas pathological compression fracture of the vertebral body (RR 0.5 [95% CI 0.2-0.9], p < 0.01) was a negative predictor of postoperative ambulatory status. 4 Kondo et al. 16 found that visceral metastases to vital organs (p < 0.01), primary renal tumors (p = 0.04), severe preoperative paralysis (p < 0.0001), and poor preoperative performance status (p < 0.0001) were significant negative predictors of postoperative ambulatory status among patients who received intraoperative radiotherapy combined with posterior decompression and stabilization. 16 Ghogawala et al. 13 determined that lower preoperative Frankel grade was a significant predictor of postsurgical ambulatory status (p < 0.01). Lei et al. 20 demonstrated that metastasis to the lumbar spine (OR 1.9 [95% CI, 1.1-3.3], p = 0.02), better preoperative 29 found that preoperative lower-extremity power classification (p < 0.001) and preoperative ambulation (p < 0.001) significantly predicted postoperative ambulation. Finally, Chaichana et al. 3 found that the primary lung histology was associated with increased odds of postoperative ambulation relative to all other primary tumor histologies.
Description of surgical techniques
Five studies compared outcomes following different surgical techniques for decompression surgery (Table  3) . 1, 12, 23, 39, 45 Three of the studies were retrospective and 2 were prospective. All 5 studies reported primary tumor sites of lung, prostate, and breast, and 4 studies reported primary renal cancers. The techniques reported on were posterior decompression and stabilization, posterior decompression without stabilization, and posterior decompression with total or subtotal tumor resection. 1, 12, 23, 39, 45 The outcomes measures used to compare surgical technique varied across the 7 included studies. Four studies used the American Spinal Injury Association (ASIA) Impairment Scale to assess neurological function. 1, 12, 23, 45 Two studies reported outcomes after decompression without stabilization. Schoeggl et al. 39 reported results of decompressive laminectomy with total or partial tumor removal. The authors found that patients undergoing this technique experienced an improvement in their quality of life based on a reduction in analgesic consumption postoperatively and a decrease in the total percentage of patients experiencing continence disorders following surgery (Table 3). 39 However, the technique did not improve quality of life outcomes for patients with preoperative paraplegia. 39 Wang et al. 45 prospectively studied a consecutive series of 140 patients receiving single-stage posterolateral transpedicular decompression and reported a 96% improvement in pain as measured through the visual analog scale score.
Two studies reported outcomes after minimally invasive decompressive surgery. Miscusi et al. 23 prospectively studied 42 patients and compared minimally invasive surgery with standard open surgery for vertebral thoracic metastases and reported that there were no significant differences in postoperative ASIA score and complication rates between the 2 cohorts. However, the authors did note that the minimally invasive group had significantly less blood loss (240 ml vs 900 ml, p < 0.01), shorter operation time (2.2 hours vs 3.2 hours, p < 0.01), and shorter bed rest length (2 days vs 4 days, p < 0.01) compared with the open surgery group. Furthermore, the authors also found that patients treated with minimally invasive surgery experienced a greater improvement in quality of life at 30-day follow-up based on the European Organisation for Research and Treatment of Cancer Quality of Life questionnaire (EORTC QLQ-30) (p < 0.01) and EORTC Bone Me- Lung (17) 1 retrospectively studied 34 patients who underwent posterior decompression and stabilization for metastatic compression of the thoracic spinal cord and found that there was no significant difference between the mean ASIA motor score at admission and discharge (72.1 vs 73.5, respectively; p = 0.7). Furthermore, the authors found no evidence that anterior approaches were superior to posterior approaches for MESCC in the thoracic spine.
Neurological Function
Eight studies reported outcomes on neurological function (Table 4) . 5, 6, 12, 17, 21, 34, 36, 41 Seven studies were retrospective and one was a nonrandomized, prospective study. The 7 retrospective studies used different decompression techniques, and the prospective study used a minimally invasive approach. Four studies reported functional status using the following methods: Frankel score, visual analog scale (VAS), Tokuhashi Score, and the KPS. 5, 6, 21, 34 The most prevalent primary tumors reported were lung (7 studies), prostate (6 studies), and breast (6 studies).
Three studies reported improvement in neurological function following decompression surgery. 12, 17, 41 Landmann et al. 17 found that sphincter function recovered in 68% of patients who underwent decompressive laminectomy and received postoperative radiation therapy compared with only 33% of patients treated by radiotherapy alone. The authors also reported that pain relief was achieved in 88% of cases after combined treatment compared with 72% of patients after radiation only. 17 Furthermore, Landmann et al. 17 found that 91% (127/140) of patients that underwent laminectomy followed by adjuvant radiotherapy had improved postoperative neurological outcomes. In their study, 82% of paraparetic patients regained ambulatory ability, 68% showed an improvement in sphincter function, and 88% achieved pain relief. Conversely, in patients treated with radiation therapy alone, only 64% of paraparetic patients became ambulatory, while 33% showed an improvement in sphincter function, and 72% became pain free.
Quraishi et al. 36 studied the effect of the timing of surgery on neurological outcome and survival in patients with MESCC. The authors found that surgery should be performed earlier rather than later relative to the onset of compression symptoms, as the Frankel grade improvement was significantly better (p = 0.05) in patients that underwent surgery within 48 hours of acute neurological deterioration relative to patients who underwent surgery 48 hours or more following presentation. 36 In a separate study, Quraishi et al. 34 were the first to use the Bilsky 6-point scale to group patients according to the degree of preoperative cord compression prior to undergoing decompression with and without stabilization. The authors found that increased preoperative compression grade was associated with greater improvement in postoperative Frankel scores. 34 Additionally, there were no significant differences between complication rates or median survival times across patient groups (p = 0.6).
radiation therapy and local Control
Four studies reported the effects of radiation therapy and local disease control for spinal metastases. 13, 25, 37, 38 Rades et al. 37 studied local control rates among patients receiving surgery and radiotherapy versus radiotherapy alone. The authors found that for 67 patients who underwent surgery with radiotherapy, the local control rate was 93% at 6 months and 86% at 12 months. 37 Rades et al. 37 included a matched-pair analysis and found that patients with MESCC from an unfavorable primary tumor (i.e., radioresistant tumors such as renal cell carcinoma and colorectal cancer) had improved functional outcome following decompressive surgery and stabilization in addition to radiotherapy, but not after laminectomy with radiotherapy. The authors suggested that laminectomy should not be considered a viable treatment option before radiotherapy in patients with MESCC. 37 Rades et al. 37 found that the type of treatment was not significantly associated with the rate of local control (p = 0.9). In another study, Rades et al. 38 analyzed data from 42 elderly (age > 65 years) patients with MESCC who underwent surgery and received radiotherapy and found that 96% of patients had local control at 6 months and 91% at 12 months. Rades et al. 38 also found that the type of treatment was not significantly associated with the rate of local control (p = 0.4).
One study found that spinal radiation before surgical decompression can have a negative impact on surgical outcomes for MESCC. Ghogawala et al. 13 reported that the major wound complication rate for patients who received radiation before surgical decompression and stabilization was 32%, significantly higher than the 12% seen in patients who had surgery first (p < 0.05).
Complications
Complications reported among the included studies were varied. However, the most commonly cited complication was wound infection or dehiscence (22 studies), which occurred in 2.5% to 16% of patients. 3 did not find a statistically significant difference in the incidence rate of complications among spinal metastases based on primary tumor site. However, Ju et al. 15 reported that younger age (p < 0.01) and instrumentation greater than 7 spinal levels (p = 0.03) were associated with increased odds of complication in patients with MESCC stemming from prostate cancer. Quraishi et al. 36 compared complication rates based on timing of surgery and determined that the incidence of complications was similar among those treated with surgery within 24 hours (40% complication rate), between 24 and 48 hours (43%), and over 48 hours (42%) following acute presentation of neurological symptoms (p = 1.0).
Primary tumor site
Five studies reported outcomes based on site of primary tumor (Table 5) . 2, 3, 11, 18, 36 All 5 studies were retrospective. The most common primary tumor site included renal cancer (4 studies), breast cancer (3 studies), prostate cancer (3 studies), gastrointestinal cancer (3 studies), and lung cancer (2 studies).
Laufer et al. 18 found that 29/39 (75%) patients who underwent decompression surgery required at least 1 reoperation regardless of tumor histology (Table 6 ). In contrast, Chaichana et al. 3 compared long-term surgical outcomes based on primary tumor histology and found that patients with primary prostate cancers had the shortest mean duration of spinal cord compression symptoms prior to surgery (p < 0.05), but they presented with motor deficits more frequently compared with all other histology types (p < 0.05). The authors also found that patients with primary breast cancer histology were more likely to present with cervical MESCC than patients with primary lung cancer histology (p = 0.04) and were more likely to present with compression fractures relative to patients with primary prostate cancers (p = 0.04). 
Miscellaneous
Seven studies reported outcomes not related to the previous topics (Table 6) . 15, 17, 32, [36] [37] [38] 45 The most common primary tumor sites included prostate cancer (6 studies), lung cancer (6 studies), breast cancer (5 studies), and renal cancer (3 studies). Five of the studies were retrospective and 2 were prospective.
Laufer et al. 18 analyzed the functional outcomes and complications associated with reoperation for MESCC and found that reoperation can improve outcomes among patients with high-grade epidural spinal cord compression with persistent metastatic tumors at previously treated spinal levels. Specifically, the authors found that 97% of patients maintained or had an improvement in functional status by one ECOG grade.
Discussion
The present study comprehensively reviews the literature on decompression surgery for spinal metastases. Included studies were classified according to the outcomes reported. Specifically, studies were categorized as reporting survival outcomes, ambulation outcomes, surgical technique, neurological function outcomes, primary tumor histology outcomes, and miscellaneous outcomes. Table 1 reported a wide range of predictors of survival, including Motzer score, Tokuhashi score, Frankel grade, KPS, and ECOG performance status. Table 2 reported several predictors of ambulatory status or motor function including Frankel grade, ECOG score, ASIA grade, and KPS. Table 3 reported different surgical techniques for decompression surgery and mostly focused on ASIA grade outcomes. Table 4 reported neurological functional outcomes and mostly reported outcomes using ASIA grade, Frankel grade, and KPS. Table 5 reported outcomes based on primary tumor site and reported a variety of long-term surgical outcomes including survival outcomes, reoperation rates, and correlations of primary tumor site with length of stay, change in Frankel grade, survival, and complications. Lastly, Table 6 reported miscellaneous outcomes including predictors of complications, sphincter function and pain relief, local control rates, stereotactic radiosurgery dosage, and the effect of surgical timing on Frankel grades. A review of these clinical parameters can improve preoperative risk counseling and help surgeons optimize their choice of surgical technique to decrease the occurrence of postoperative complications and improve patient quality of life.
Predictors of survival
Survival was the most commonly reported outcome. Different scoring algorithms have been proposed to improve survival prediction among patients with spinal metastases who undergo decompression surgery. Three studies found that KPS was associated with survival following decompression surgery. 7, 15, 28 Ju et al. 15 found that a better preoperative KPS (defined as KPS ≥ 80%) was the only significant predictor of survival in a multivariable study of patients with prostate cancer metastatic to the spine (HR 6.1 [95% CI 1.3-28.5], p = 0.02). Padalkar et al. 28 also found that increased KPS was significantly associated with greater median survival times in patients treated with decompression with instrumentation for spinal metastases. Crnalic et al. 7 reported that a KPS of 80%-100% was significantly associated with prolonged survival, with a median survival of 5 months.
Predictors of Ambulatory status/Motor Function
A prior study found that ambulatory ability is the single most important factor for surgeons when deciding if surgical intervention is an appropriate treatment for patients with metastatic spinal cord compression. 22 We found that 8 studies reported that preoperative ambulatory or preoperative motor status was a significant predictor of postoperative ambulatory status. 4, 13, 16, 20, [29] [30] [31] 33 However, we did not find any evidence of a surgical decision-making tool that uses postoperative ambulation as an outcome following decompression surgery for spinal metastases. Future studies are warranted to develop evidence-based decisionmaking tools that use postoperative ambulatory status as an outcome. These decision tools may significantly improve preoperative patient risk counseling and patient selection for decompression surgery for spinal metastases.
Description of surgical techniques
We found 5 studies that identified outcomes following different surgical techniques for decompression surgery among patients with spinal metastases. 1, 12, 23, 39, 45 In reviewing the aforementioned studies on surgical technique, the only prospective studies were those by Miscusi et al. 23 and Wang et al. 45 Furthermore, no studies reported using matching techniques, such as propensity matching, which help mitigate bias in observational studies. Therefore, despite promising evidence of the benefits of the innovative surgical techniques described above, larger prospective, randomized trials or rigorously designed observational studies are needed to appropriately evaluate the effectiveness of different surgical approaches for decompression surgery among patients with spinal metastases.
Neurological Function
Two studies found that neurological outcomes may improve if decompression surgery is performed within 48 hours of MESCC symptom presentation. Fürstenberg et al. 12 studied 35 patients who underwent early surgical treatment for MESCC and found that early surgical treatment was associated with improved neurological outcomes as measured by the ASIA grade (p = 0.02). Similarly, Quraishi et al. 36 found that surgery should be performed earlier rather than later among patients with MESCC, as the Frankel grade improvement was significantly greater (p = 0.05) among patients who received surgery within 48 hours of presenting with symptoms relative to patients who received surgery after 48 hours.
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Conclusions
This work presents a comprehensive systematic review of outcomes following decompression surgery for metastatic spinal tumors of varied primary tumor sites. The present study highlights significant predictors of survival, ambulation, and functional status following decompression surgery for metastatic spine disease. The results of the data presented herein also identify significant gaps in the literature, which may help spur additional investigation of the optimal surgical management of patients with MESCC.
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